As of 4:00pm ET
| -0.05 / -0.65%|
The 4 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 12.50, with a high estimate of 14.00 and a low estimate of 9.00. The median estimate represents a +62.34% increase from the last price of 7.70.
The current consensus among 4 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.